Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Altimmune (ALT) Return on Sales (2016 - 2025)

Altimmune (ALT) has disclosed Return on Sales for 16 consecutive years, with 2226.54% as the latest value for Q4 2025.

  • Quarterly Return on Sales fell 1081766.0% to 2226.54% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 69.39% through Dec 2025, up 26351.0% year-over-year, with the annual reading at 69.39% for FY2025, 26351.0% up from the prior year.
  • Return on Sales for Q4 2025 was 2226.54% at Altimmune, up from 3802.8% in the prior quarter.
  • The five-year high for Return on Sales was 13044.2% in Q4 2024, with the low at 11756.5% in Q3 2022.
  • Average Return on Sales over 5 years is 1507.72%, with a median of 895.96% recorded in 2023.
  • The sharpest move saw Return on Sales plummeted -1154441bps in 2022, then soared 1212377bps in 2024.
  • Over 5 years, Return on Sales stood at 16.69% in 2021, then tumbled by -5104bps to 835.12% in 2022, then surged by 210bps to 920.43% in 2023, then surged by 1317bps to 13044.2% in 2024, then crashed by -83bps to 2226.54% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 2226.54%, 3802.8%, and 4429.2% for Q4 2025, Q3 2025, and Q2 2025 respectively.